Establishment and characterization of novel human uterine leiomyosarcoma cell lines

International Journal of Oncology

Volumn 37, Issue 1, 2010, Pages 125-131

  Tanaka, Tetsuji ^a   Toujima, Saori ^a   Toyoda, Shinji ^b   Takeuchi, Satoru ^c   Umesaki, Naohiko ^d  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Nara Hospital   (Japan)

^c IWATE MEDICAL UNIVERSITY   (Japan)

^d Izumi City Hospital   (Japan)

Author keywords

Drug sensitivity; Karyotype; Leiomyosarcoma; Uterus

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; NEDAPLATIN; PACLITAXEL; PEPLEOMYCIN; PIRARUBICIN;

ADVANCED CANCER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SUSPENSION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; DRUG SENSITIVITY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KARYOTYPING; LEIOMYOSARCOMA; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL; UTERUS LEIOMYOSARCOMA; UTERUS SARCOMA; ADULT; ALGORITHM; ANIMAL; BAGG ALBINO MOUSE; CULTURE TECHNIQUE; DRUG SCREENING; FEMALE; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; UTERUS CANCER; XENOGRAFT;

ADULT; ALGORITHMS; ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FLOW CYTOMETRY; HUMANS; LEIOMYOSARCOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; UTERINE NEOPLASMS;

EID: 77953196222     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000660     Document Type: Article

References (9)

1. Ishiwata I, Nozawa S, Nagai S, Kurihara S and Mikata A: Establishment of a human leiomyosarcoma cell line. Cancer Res 37: 658-664, 1977.
2. Tanaka T, Nakajima S and Umesaki N: Cellular heterogeneity in long-term surviving cells isolated from eutopic endometrial, ovarian endometrioma and adenomyosis tissues. Oncol Rep 10: 1150-1160, 2003.
3. Gibas Z, Prout GR, Conolly JG, Pontes JE and Sandberg AA: Non-random chromosome changes in transitional cell carcinoma of the bladder. Cancer Res 44: 1257-1264, 1984. (Pubitemid 14151537)
4. Toshida MA, Ohyashiki K, Ochi H, Gibas Z, Pontes JE, Prout GR, Huben R and Sandberg AA: Cytogenetic studies of tumor tissue rom patients with non-familial renal cell carcinoma. Cancer Res 46: 2139-2147, 1986.
5. Yunis JJ: New chromosome techniques in the study of human neoplasia. Hum Pathol 12: 540-549, 1981. (Pubitemid 11081015)
6. Tanaka T, Toujima S, Otani T, Minami S, Yamoto M and Umesaki N: Expression and function of activin receptors in human endometrial adenocarcinoma cells. Int J Oncol 23: 657-663, 2003.
7. Bai T, Tanaka T, Yukawa K and Umesaki N: A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2′- deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. Int J Oncol 28: 497-508, 2006.
8. Tanaka T, Toujima S and Umesaki N: Growth-inhibitory signals by activin A do not affect anticancer drug-sensitivity and acquired multi-drug-resistance in human ovarian endometrioid adenocarcinoma OVK-18 cells. Oncol Rep 11: 667-671, 2004.
9. Tanaka T, Toujima S, Utsunomiya T, Yukawa K and Umesaki N: Experimental characterization of recurrent ovarian immature teratoma cells after optimal surgery. Oncol Rep 20: 13-23, 2008.